Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $431000.0.

  • ProPhase Labs' Share-based Compensation fell 3223.27% to $431000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 4381.93%. This contributed to the annual value of $3.6 million for FY2024, which is 288.46% up from last year.
  • Per ProPhase Labs' latest filing, its Share-based Compensation stood at $431000.0 for Q3 2025, which was down 3223.27% from $508000.0 recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Share-based Compensation peaked at $2.0 million during Q3 2022, and registered a low of $428000.0 during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $745000.0 (2021), whereas its average is $831736.8.
  • In the last 5 years, ProPhase Labs' Share-based Compensation soared by 44343.43% in 2021 and then crashed by 6721.21% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Share-based Compensation stood at $745000.0 in 2021, then skyrocketed by 35.17% to $1.0 million in 2022, then crashed by 32.87% to $676000.0 in 2023, then fell by 8.73% to $617000.0 in 2024, then tumbled by 30.15% to $431000.0 in 2025.
  • Its Share-based Compensation stands at $431000.0 for Q3 2025, versus $508000.0 for Q2 2025 and $521000.0 for Q1 2025.